Pharmacists Ready to Dispense Mifepristone with Basic Training
The study explores the readiness and comfort of pharmacists in dispensing mifepristone, a medication commonly used for abortion and early miscarriage care, in light of recent changes in FDA regulations.
- The study was conducted through in-depth interviews with 21 US-based pharmacists and pharmacy trainees.
- The interviews took place between June and December of 2021, a period when few pharmacists were allowed to dispense mifepristone.
According to the World Health Organization, medical abortion using a combination of mifepristone and misoprostol is highly effective during the first trimester of pregnancy.
- Participants reported varied knowledge about medications for miscarriage and abortion but described themselves as generally knowledgeable about medications.
- Most participants said they would feel ready to dispense mifepristone, and many described dispensing misoprostol without difficulty.
- Potential challenges specific to mifepristone dispensing included employer hesitation and colleague refusals.
- To assure successful dispensing, participants recommended basic training and fact sheets; relationships with prescribers for follow-up; and policies for prescription transfers in the event of refusal.
- Nearly all participants would feel ready to dispense mifepristone with some basic training.
More on Contraception/Pregnancy